teva ceo

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

Israel's Teva Pharmaceuticals and GlaxoSmithKline (GSK) have been disputing over this patent lawsuit since 2014.

By REUTERS
15/05/2023
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy